Donn Young is the former director of the Ohio State University Comprehensive Cancer Center Biostatistics Unit where he spent 32 years designing, conducting, and analyzing cancer research studies. Like ...

Astellas and Pfizer's Xtandi plus ADT showed a decrease in mortality risk in a metastatic hormone-sensitive prostate cancer ...

The aggressiveness of a cancer is based on several factors, including the tumor's grade and stage, and the cells' genetic ...